This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Jul 1;111(7):644-645.

doi: 10.1093/jnci/djy195.

Cost-Effective But Unaffordable: The CAR-T Conundrum

Ashley A Leech¹, Stacie B Dusetzina¹

Affiliations

PMID: 30561705
DOI: 10.1093/jnci/djy195

Editorial

Cost-Effective But Unaffordable: The CAR-T Conundrum

Ashley A Leech et al. J Natl Cancer Inst. 2019.

. 2019 Jul 1;111(7):644-645.

doi: 10.1093/jnci/djy195.

Authors

Ashley A Leech¹, Stacie B Dusetzina¹

Affiliation

¹ Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN.

PMID: 30561705
DOI: 10.1093/jnci/djy195

No abstract available

PubMed Disclaimer

Comment on

Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia.
Sarkar RR, Gloude NJ, Schiff D, Murphy JD. Sarkar RR, et al. J Natl Cancer Inst. 2019 Jul 1;111(7):719-726. doi: 10.1093/jnci/djy193. J Natl Cancer Inst. 2019. PMID: 30551196 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems